ExVivo is a startup based in Canada. Brouky records 1 investor associated with the company.
ExVivo develops a next generation medical diagnostic tool for allergy testing using microfluidics technology to make testing safe, simple, and non-invasive.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.